Compare ALKS & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALKS | SNEX |
|---|---|---|
| Founded | 1987 | 1924 |
| Country | Ireland | United States |
| Employees | N/A | 5400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.9B |
| IPO Year | 2012 | 1996 |
| Metric | ALKS | SNEX |
|---|---|---|
| Price | $27.66 | $105.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | $43.43 | ★ $122.00 |
| AVG Volume (30 Days) | ★ 1.7M | 309.5K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.43 | ★ 2.50 |
| Revenue | $1,475,899,000.00 | ★ $132,378,200,000.00 |
| Revenue This Year | $24.06 | N/A |
| Revenue Next Year | $4.53 | $3.69 |
| P/E Ratio | ★ $19.41 | $42.81 |
| Revenue Growth | N/A | ★ 32.53 |
| 52 Week Low | $25.17 | $65.58 |
| 52 Week High | $36.32 | $132.57 |
| Indicator | ALKS | SNEX |
|---|---|---|
| Relative Strength Index (RSI) | 28.59 | 34.85 |
| Support Level | $25.65 | $92.71 |
| Resistance Level | $28.75 | $105.45 |
| Average True Range (ATR) | 1.09 | 4.94 |
| MACD | -0.38 | -3.26 |
| Stochastic Oscillator | 8.03 | 7.71 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.